Brenda Leahy M.S., R.D. is an experienced healthcare professional with a strong background in oncology and nutrition management. Currently serving as the Diagnostics Key Account Manager for Adaptive Biotechnologies Corp. since August 2020, Brenda specializes in the introduction of next-generation sequencing for lymphoid malignancies. Previous roles include Oncology Account Manager at Acrotech Biopharma, where Brenda communicated therapeutic information for radioimmunotherapy drugs, and Account Manager for Outpatient Oncology at Abbott, focusing on the nutritional needs of oncology patients. Brenda's career also encompasses strategic roles at Nestlé Health Science, Sanofi, and Pfizer, along with military service as a Registered Dietitian in the US Navy. Educational qualifications include a Bachelor of Health Science in Clinical Nutrition from the University of Florida and a Master of Science in Management and Leadership from Nova Southeastern University.